Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FLD | FOLD HOLDINGS INC | $29.85M | $28.21M | -$66.61M | -$72.96M | -$1.54 | -2.54% | N/A | N/A | N/A | |||
| TRAX | FIRST TRACKS BIOTHERAPEUTICS INC | $1.30B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| PAC | PACIFIC AIRPORT GROUP | $10.28B | $2.32B | $1.23B | $535.56M | $10.60 | 42.54% | 30.99% | 28.51% | 41.06% | 2026-10-19 | ||
| CABA | CABALETTA BIO INC | $462.86M | $0.00 | -$159.94M | -$181.32M | -$1.52 | N/A | N/A | N/A | N/A | |||
| AGMB | AGOMAB THERAPEUTICS NV | $636.50M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| IRON | DISC MEDICINE INC | $2.69B | $0.00 | -$241.17M | -$245.89M | -$6.58 | N/A | N/A | N/A | N/A | 2026-11-05 | ||
| ARWR | ARROWHEAD PHARMACEUTICALS INC | $11.70B | $669.50M | -$181.49M | -$319.95M | -$2.25 | 16.85% | 44.13% | N/A | N/A | |||
| LONA | LEONABIO INC | $65.20M | $0.00 | -$140.22M | -$141.46M | -$23.11 | N/A | N/A | N/A | N/A | 2026-11-05 | ||
| IMMX | IMMIX BIOPHARMA INC | $868.49M | $0.00 | -$39.40M | -$39.92M | -$0.88 | N/A | N/A | N/A | N/A | |||
| SKHY | SK HYNIX INC | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| RBRK | RUBRIK INC | $17.96B | $1.54B | -$175.48M | -$254.43M | -$1.27 | 42.45% | N/A | N/A | N/A | |||
| TLX | TELIX PHARMACEUTICALS LTD | $3.84B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| VKTX | VIKING THERAPEUTICS INC | $3.73B | $0.00 | -$534.35M | -$534.80M | -$4.67 | N/A | N/A | N/A | N/A | 2026-10-28 | ||
| BRSP | BRIGHTSPIRE CAPITAL INC | $563.03M | $204.42M | $25.70M | -$26.86M | -$0.24 | 4.70% | -2.43% | N/A | N/A | 2026-10-27 | ||
| ERAS | ERASCA INC | $5.55B | $0.00 | -$284.29M | -$287.22M | -$0.95 | N/A | N/A | N/A | N/A | |||
| ARVN | ARVINAS INC | $552.51M | $316.70M | $14.90M | $9.30M | $0.27 | -15.05% | 66.28% | N/A | N/A | 2026-11-04 | ||
| BLND | BLEND LABS INC | $333.48M | $129.97M | $5.54M | -$19.37M | -$0.08 | 6.80% | 1.20% | N/A | N/A | 2026-11-05 | ||
| INFQ | INFLEQTION INC | $2.96B | $55.46M | -$83.09M | -$88.71M | -$1.16 | 30.76% | N/A | N/A | N/A | |||
| ACRS | ACLARIS THERAPEUTICS INC | $783.10M | $8.22M | -$75.32M | -$75.74M | -$0.58 | -51.05% | 4.39% | N/A | N/A | 2026-11-05 | ||
| IPX | IPERIONX LTD | $627.91M | $0.00 | N/A | -$53.88M | -$1.60 | N/A | N/A | N/A | N/A | 2026-09-29 | ||
| ADTN | ADTRAN HOLDINGS INC | $614.37M | $1.14B | $97.52M | -$26.08M | -$0.28 | 15.75% | 16.34% | N/A | N/A | 2026-11-02 | ||
| LTRX | LANTRONIX INC | $244.74M | $120.90M | -$872.00k | -$4.18M | -$0.10 | -1.65% | 11.08% | N/A | N/A | 2026-11-04 | ||
| CNTX | CONTEXT THERAPEUTICS INC | $32.16M | $0.00 | -$45.81M | -$45.96M | -$0.48 | N/A | N/A | N/A | N/A | 2026-11-04 | ||
| ATHE | ALTERITY THERAPEUTICS LTD | $73.12M | $2.59M | -$16.68M | -$16.76M | -$0.96 | -50.37% | -5.85% | N/A | N/A | |||
| SGRY | SURGERY PARTNERS INC | $1.88B | $3.37B | $429.10M | -$88.60M | -$0.69 | 3.99% | 9.90% | N/A | N/A | |||
| COAG | HEMAB THERAPEUTICS HOLDINGS INC | $1.84B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| BWAY | BRAINSWAY LTD | $545.58M | $60.70M | $13.54M | $9.44M | $0.25 | 31.71% | 18.29% | 66.67% | N/A | |||
| ELAN | ELANCO ANIMAL HEALTH INC | $11.58B | $5.02B | $775.00M | -$199.00M | -$0.41 | 11.95% | 1.99% | N/A | N/A | 2026-11-04 | ||
| NKTX | NKARTA INC | $208.43M | $0.00 | -$105.57M | -$117.32M | -$1.57 | N/A | N/A | N/A | N/A | |||
| BTGO | BITGO HOLDINGS INC | $899.22M | $20.07B | -$109.10M | -$95.75M | -$1.19 | 226.70% | N/A | N/A | N/A | |||
| BIOA | BIOAGE LABS INC | $389.66M | $10.36M | -$93.79M | -$94.46M | -$2.38 | 168.06% | N/A | N/A | N/A | 2026-11-05 | ||
| GENB | GENERATE BIOMEDICINES INC | $2.02B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2026-11-05 | ||
| ZGN | ERMENEGILDO ZEGNA NV | $3.12B | $2.30B | $538.49M | $144.33M | N/A | 0.19% | 9.37% | N/A | N/A | |||
| VCYT | VERACYTE INC | $3.29B | $561.90M | $139.68M | $114.48M | $1.44 | 17.28% | 28.97% | 311.43% | N/A | 2026-11-03 | ||
| ABVX | ABIVAX SA | $9.37B | $5.79M | -$249.95M | -$390.82M | -$5.28 | -57.55% | N/A | N/A | N/A | 2026-09-21 | ||
| TYRA | TYRA BIOSCIENCES INC | $1.31B | $0.00 | -$148.03M | -$148.57M | -$2.39 | N/A | N/A | N/A | N/A | 2026-11-04 | ||
| AKTS | AKTIS ONCOLOGY INC | $1.30B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| CEVA | CEVA INC | $816.75M | $115.73M | -$37.00k | -$10.98M | -$0.40 | 8.82% | 1.21% | N/A | N/A | |||
| LTM | LATAM AIRLINES GROUP SA | $29.45B | $14.27B | $2.34B | $1.46B | $4.95 | 11.16% | 29.45% | 53.28% | N/A | |||
| NEXN | NEXXEN INTERNATIONAL LTD | $267.01M | $382.86M | $90.99M | $13.07M | $0.44 | 2.99% | 5.71% | -70.27% | -14.59% | |||
| KARD | KARDIGAN INC | $1.73B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| SLDB | SOLID BIOSCIENCES INC | $932.86M | $0.00 | -$203.08M | -$207.10M | -$1.91 | N/A | -100.00% | N/A | N/A | 2026-11-02 | ||
| QNT | QUANTINUUM INC | $12.91B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| SVCO | SILVACO GROUP INC | $227.37M | $72.49M | -$20.47M | -$22.06M | -$0.71 | 31.86% | N/A | N/A | N/A | |||
| KRRO | KORRO BIO INC | $203.36M | $2.38M | -$102.34M | -$106.64M | -$10.00 | -62.08% | -41.67% | N/A | N/A | |||
| CX | CEMEX SAB DE CV | $15.51B | $16.13B | $3.09B | $960.00M | $0.22 | 0.43% | 4.95% | 1.84% | N/A | 2026-10-26 | ||
| CGEM | CULLINAN THERAPEUTICS INC | $1.33B | $0.00 | -$204.37M | -$205.35M | -$3.11 | N/A | -100.00% | N/A | N/A | 2026-11-05 | ||
| OMAB | CENTRAL NORTH AIRPORT GROUP | $4.77B | $918.55M | $573.15M | $307.35M | $6.37 | 22.56% | 26.87% | 25.39% | 40.38% | 2026-10-22 | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | $320.77M | $409.00k | -$112.87M | -$116.43M | -$1.33 | -66.88% | -47.29% | N/A | N/A | |||
| JHX | JAMES HARDIE INDUSTRIES PLC | $16.53B | $5.41B | $1.18B | $145.70M | $0.25 | 42.93% | 11.60% | -67.53% | -21.52% | |||
| PAAS | PAN AMERICAN SILVER CORP | $21.21B | $3.13B | $1.79B | $930.05M | $3.32 | 36.14% | 16.17% | 128.97% | 18.68% | |||
| CLS | CELESTICA INC | $39.85B | $15.59B | $1.55B | $1.12B | $9.71 | 47.30% | 22.77% | 110.17% | 69.70% | 2026-10-26 | ||
| CRVO | CERVOMED INC | $38.86M | $331.30k | -$30.35M | -$30.35M | -$3.22 | -95.74% | N/A | N/A | N/A | |||
| KLRA | KAILERA THERAPEUTICS INC | $1.81B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| MAZE | MAZE THERAPEUTICS INC | $1.37B | $20.00M | -$126.62M | -$133.59M | -$2.47 | 700.00% | N/A | N/A | N/A | 2026-11-05 | ||
| FDMT | 4D MOLECULAR THERAPEUTICS INC | $727.57M | $92.01M | -$171.05M | -$179.18M | -$2.63 | 278,712.12% | 31.93% | N/A | N/A | |||
| MSLE | SATELLOS BIOSCIENCE INC | $203.18M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| OLMA | OLEMA PHARMACEUTICALS INC | $894.23M | $0.00 | -$202.91M | -$204.57M | -$2.13 | N/A | N/A | N/A | N/A | |||
| HELP | CYBIN INC | $803.93M | $0.00 | -$123.35M | -$123.43M | -$2.99 | N/A | N/A | N/A | N/A | |||
| ELOX | ELOXX PHARMACEUTICALS INC | $63.57M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| SGMT | SAGIMET BIOSCIENCES INC | $676.29M | $0.00 | -$46.93M | -$47.08M | -$1.29 | N/A | N/A | N/A | N/A | |||
| NVCT | NUVECTIS PHARMA INC | $781.63M | $0.00 | -$27.85M | -$30.28M | -$1.31 | N/A | N/A | N/A | N/A | 2026-11-03 | ||
| ATTO | ATTOVIA THERAPEUTICS INC | $1.04B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.